4 unknown, 2 completed, 1 active not recruiting, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Non functioning pancreatic endocrine tumor: new trials by email Literature Review of Non functioning pancreatic endocrine tumor trials Research Report on Non functioning pancreatic endocrine tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm Histopathological review, long-term prognosis and quality of life follow-up - Non Functioning Pancreatic Endocrine Tumor | Unknown | Fudan University | 800 | 2023-05-01 | 2023-09-13 | |
| Diagnostic Accuracy of Preoperative Diagnostic Procedure in the Assessment of Lymph Node Metastases by NF-PanNENs Non Functioning Pancreatic Endocrine Tumor | Completed | IRCCS San Raffaele | 100 | 2018-11-01 | 2023-03-01 | |
| Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Functioning Pancreatic Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 298 | 2018-10-26 | 2026-10-26 |
| EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors EUS-guided ethanol ablation, EUS-guided lauromacrogol ablation - Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor | Not applicable | Unknown | Guangxi Medical University | 20 | 2018-09-28 | 2022-10-04 |
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor Capecitabine, Temozolomide, Veliparib - Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma | Phase 1 | Withdrawn | Vanderbilt-Ingram Cancer Center | 2017-12-01 | 2017-09-28 | |
| Asymptomatic Small Pancreatic Endocrine Neoplasms. Radiological imaging studies, Quality of Life Assessment - Non Functioning Pancreatic Endocrine Tumor | Unknown | IRCCS San Raffaele | 1000 | 2017-09-01 | 2024-01-18 | |
| Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin Laboratory Biomarker Analysis, Pharmacological Study, Ribociclib - Advanced Digestive System Neuroendocrine Neoplasm, Duodenal Neuroendocrine Tumor G1 | Phase 2 | Completed | M.D. Anderson Cancer Center | 21 | 2015-08-25 | 2020-10-30 |
| Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors Chromogranin A - Non Functioning Pancreatic Endocrine Tumor | Phase 4 | Unknown | Asan Medical Center | 111 | 2012-06-01 | 2016-05-03 |
Adenoma, Islet Cell (3) · Neuroendocrine Tumors (2) · Adrenal Cortex Neoplasms (1) · Carcinoid Tumor (1) · Carcinoma, Medullary (1) · Carcinoma, Merkel Cell (1) · Glucagonoma (1) · Insulinoma (1) · Lymphatic Metastasis (1) · Multiple Endocrine Neoplasia Type 1 (1) · Multiple Endocrine Neoplasia Type 2a (1) · Multiple Endocrine Neoplasia Type 2b (1) · Pheochromocytoma (1) · Somatostatinoma (1)
Neoplasms (6) · Neoplasms by Site (5) · Adenoma (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Endocrine Gland Neoplasms (4) · Endocrine System Diseases (4) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4) · Pancreatic Diseases (4) · Pancreatic Neoplasms (4) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Adenocarcinoma (1)
Capecitabine (1) · Chromogranin A (1) · Magnetic Resonance Spectroscopy (1) · Phantoms, Imaging (1) · Specimen Handling (1) · Temozolomide (1) · X-Rays (1) · cabozantinib (1) · ribociclib (1) · veliparib (1)
IRCCS San Raffaele (2) · Asan Medical Center (1) · Fudan University (1) · Guangxi Medical University (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Vanderbilt-Ingram Cancer Center (1)
China (2) · Italy (2) · United States (2)
Jennifer A Chan (1) · Jordan Berlin, M.D. (1) · Massimo Falconi, Professor (1) · Nageshwara V Dasari (1) · Shanyu Qin, MD,Ph.D (1) · Shunrong Ji, PhD (1) · Songcheol Kim, MD PhD (1) · Stefano Partelli, MD, PhD (1) · Xianjun Yu, MD, PhD (1)
PMID 28448665, PMID 29739948, PMID 33152282, PMID 33425946, PMID 35930017, PMID 39282913, PMID 41524552
P30CA016672 (1), U10CA180821 (1)